Peter Hellstern

3.6k total citations
115 papers, 2.6k citations indexed

About

Peter Hellstern is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, Peter Hellstern has authored 115 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 27 papers in Cardiology and Cardiovascular Medicine and 24 papers in Biochemistry. Recurrent topics in Peter Hellstern's work include Blood Coagulation and Thrombosis Mechanisms (30 papers), Blood transfusion and management (24 papers) and Hemophilia Treatment and Research (21 papers). Peter Hellstern is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (30 papers), Blood transfusion and management (24 papers) and Hemophilia Treatment and Research (21 papers). Peter Hellstern collaborates with scholars based in Germany, Switzerland and United States. Peter Hellstern's co-authors include Hannelore Haubelt, Bjarte G. Solheim, Michael Köhler, Bernhard R. Winkelmann, E. Wenzel, Bernhard O. Boehm, U.T. Seyfert, Winfried März, Jochen Senges and Rainer B. Zotz and has published in prestigious journals such as New England Journal of Medicine, Blood and Plastic & Reconstructive Surgery.

In The Last Decade

Peter Hellstern

112 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hellstern Germany 28 1.1k 695 500 451 442 115 2.6k
Maureen G. Conlan United States 30 948 0.9× 507 0.7× 367 0.7× 117 0.3× 297 0.7× 73 2.7k
James P. Isbister Australia 25 554 0.5× 933 1.3× 155 0.3× 644 1.4× 463 1.0× 113 2.1k
Majed A. Refaai United States 27 762 0.7× 822 1.2× 985 2.0× 627 1.4× 273 0.6× 108 3.0k
Joanna M. Heal United States 34 1.5k 1.4× 2.1k 3.0× 172 0.3× 748 1.7× 494 1.1× 83 3.6k
Antonio Ordinas Spain 35 2.1k 1.9× 443 0.6× 629 1.3× 236 0.5× 104 0.2× 173 3.6k
Rebecca Cardigan United Kingdom 31 1.1k 1.0× 1.5k 2.1× 122 0.2× 687 1.5× 852 1.9× 119 2.9k
Janice G. McFarland United States 36 2.7k 2.4× 1.0k 1.5× 125 0.3× 597 1.3× 262 0.6× 74 4.2k
Gary Moroff United States 31 1.5k 1.4× 1.6k 2.3× 86 0.2× 240 0.5× 707 1.6× 92 2.8k
Andrew Mumford United Kingdom 38 3.0k 2.7× 307 0.4× 949 1.9× 288 0.6× 100 0.2× 137 5.0k
Yoke Lin Fung Australia 24 335 0.3× 549 0.8× 160 0.3× 419 0.9× 128 0.3× 89 2.1k

Countries citing papers authored by Peter Hellstern

Since Specialization
Citations

This map shows the geographic impact of Peter Hellstern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hellstern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hellstern more than expected).

Fields of papers citing papers by Peter Hellstern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hellstern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hellstern. The network helps show where Peter Hellstern may publish in the future.

Co-authorship network of co-authors of Peter Hellstern

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hellstern. A scholar is included among the top collaborators of Peter Hellstern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hellstern. Peter Hellstern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hellstern, Peter, et al.. (2025). Non-linear association of coagulation factor XI with mortality. Med. 7(2). 100934–100934.
2.
Marquardt, Lars, et al.. (2009). Leukocyte-Platelet Aggregates in Acute and Subacute Ischemic Stroke. Cerebrovascular Diseases. 28(3). 276–282. 47 indexed citations
3.
Bach, Jürgen, Georg Endler, Christine Mannhalter, & Peter Hellstern. (2008). Coagulation factor XII activity, activated factor XII, distribution of factor XII C46T gene polymorphism and coronary risk: reply to a rebuttal. Journal of Thrombosis and Haemostasis. 6(6). 1055–1056. 3 indexed citations
4.
Hellstern, Peter & Walter Hitzler. (2007). Thrombozytenkonzentrate aus Vollblutspenden – time to say goodbye. Transfusion Medicine and Hemotherapy. 34(3). 208–210.
5.
Isgro, Frank, et al.. (2005). Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis. 93(6). 1101–1107. 160 indexed citations
6.
Haubelt, Hannelore, Melinda Simon, Christoph Anders, & Peter Hellstern. (2004). [Platelet function tests for monitoring of acetylsalicylic acid: clinical significance in antiplatelet treatment].. PubMed. 24(3). 196–202. 15 indexed citations
7.
8.
Hellstern, Peter. (1999). Production and Composition of Prothrombin Complex Concentrates. Thrombosis Research. 95(4). S7–S12. 45 indexed citations
9.
Thies, Karl‐Christian, et al.. (1994). Detection of Primary HIV Infection by a Second-Generation HIV(p24) Antigen Test. Transfusion Medicine and Hemotherapy. 21(5). 333–336. 2 indexed citations
10.
Hellstern, Peter, et al.. (1993). Prospective Study on Efficacy and Tolerability of Solvent/ Detergent-Treated Plasma in Intensive Care Unit Patients. Transfusion Medicine and Hemotherapy. 20(Suppl. 2). 16–18. 18 indexed citations
11.
Hellstern, Peter, et al.. (1990). Monitoring of intravenous heparin therapy by a modified chromogenic anti factor xa assay. Annals of Hematology. 60(2). 114. 2 indexed citations
12.
Schimpf, K., H.H. Brackmann, W. Kreuz, et al.. (1989). Absence of Anti-Human Immunodeficiency Virus Types 1 and 2 Seroconversion after the Treatment of Hemophilia A or von Willebrand's Disease with Pasteurized Factor VIII Concentrate. New England Journal of Medicine. 321(17). 1148–1152. 53 indexed citations
13.
Seifried, Erhard, et al.. (1988). In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. Annals of Hematology. 57(6). 341–345. 6 indexed citations
14.
Hellstern, Peter, HOLGER SCHWERDT, Cem Özbek, et al.. (1987). High-Dose Systemic Streptokinase and Acylated Streptokinase-Plasminogen Complex (BRL 26921) in Acute Myocardial Infarction: Alterations of the Fibrinolytic System and Clearance of Fibrinolytic Activity. Pathophysiology of Haemostasis and Thrombosis. 17(1-2). 32–39. 17 indexed citations
15.
Hellstern, Peter, et al.. (1987). Measurement of Factor VIII Procoagulant Antigen in Normal Subjects and in Hemophilia A Patients by an Immunoradiometric Assay and by an Enzyme-Linked Immunosorbent Assay. Pathophysiology of Haemostasis and Thrombosis. 17(4). 173–181. 4 indexed citations
16.
Hellstern, Peter, et al.. (1985). Gray platelet syndrome: Selective ?-granule deficiency and thrombocytopenia due to increased platelet turnover. Annals of Hematology. 50(6). 331–340. 31 indexed citations
17.
Erfle, Volker, Rüdiger Hehlmann, W. Mellert, et al.. (1985). Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemopheliacs and other patients chronically substituted with blood products. Annals of Hematology. 51(4). 243–249. 3 indexed citations
18.
Hellstern, Peter, et al.. (1985). The use of heat-treated factor VIII-concentrates in von willebrand's disease. Annals of Hematology. 50(1). 25–27. 19 indexed citations
19.
Hellstern, Peter, et al.. (1985). Combined Dys-Form of Homozygous Factor XI Deficiency and Heterozygous Factor XII Deficiency. Pathophysiology of Haemostasis and Thrombosis. 15(3). 215–219. 4 indexed citations
20.
Miyashita, C., et al.. (1984). In vitro characterization of commercial factor VIII concentrates: Long-term follow-up. Annals of Hematology. 49(1). 53–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen G. Conlan Breakdown of academic impact, for papers by James P. Isbister Breakdown of academic impact, for papers by Majed A. Refaai Breakdown of academic impact, for papers by Joanna M. Heal Breakdown of academic impact, for papers by Antonio Ordinas Breakdown of academic impact, for papers by Rebecca Cardigan Breakdown of academic impact, for papers by Janice G. McFarland Breakdown of academic impact, for papers by Gary Moroff Breakdown of academic impact, for papers by Andrew Mumford Breakdown of academic impact, for papers by Yoke Lin Fung
Rankless by CCL
2026